Los Angeles Capital Management LLC Has $33.66 Million Stock Position in Cigna Group $CI

Los Angeles Capital Management LLC cut its stake in shares of Cigna Group (NYSE:CI) by 16.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 101,819 shares of the health services provider’s stock after selling 19,451 shares during the period. Los Angeles Capital Management LLC’s holdings in Cigna Group were worth $33,659,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Valeo Financial Advisors LLC grew its holdings in Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Nuveen LLC bought a new stake in shares of Cigna Group in the 1st quarter valued at $727,905,000. Price T Rowe Associates Inc. MD lifted its holdings in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. GQG Partners LLC grew its stake in Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after acquiring an additional 457,052 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Performance

CI opened at $264.54 on Friday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The business has a 50 day moving average of $293.24 and a 200-day moving average of $303.54. The stock has a market cap of $70.66 billion, a price-to-earnings ratio of 14.44, a PEG ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the prior year, the business earned $7.51 EPS. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. Cigna Group’s payout ratio is presently 26.64%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CI. Guggenheim decreased their price objective on Cigna Group from $350.00 to $309.00 in a research report on Friday, October 31st. Morgan Stanley reissued an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a research report on Friday, October 31st. Leerink Partners cut their price objective on shares of Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. JPMorgan Chase & Co. lowered their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. Finally, Cantor Fitzgerald reduced their price target on Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $339.73.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.70% of the stock is owned by company insiders.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.